Search:

Home Index Back issues Contact

 

Here is a convenient index of articles that have appeared in recent issues of the journal. The article titles are presented, with the keyword given first. Click on any title to find out more about the content.

 

Article title

Issue

 

Advanced non-small cell lung cancer: A new service model for patients with advanced non-small cell lung cancer
Clare Green MBBS MRCP Consultant Clinical Oncologist, Southampton General Hospital; Julie Adams RGN Chemotherapy Ward Manager; Suzanne Elvin BPharm(Hons) MRPharmS CertPharmPrac IP Technical Services Manager – Pharmacy, Royal Hampshire County Hospital, Winchester
5.2
Advanced NSCLC, Treatment options for
Nihal Shah MRCP FRCR MD Consultant Clinical Oncologist, Mount Vernon Cancer Treatment Centre, Northwood
1.1
Advice can be hard to get, say patients
Jesme Baird MB ChB MBA Director of Patient Care, The Roy Castle Lung Cancer Foundation
1.3
Agenda, Putting lung cancer on the
Michael D Peake, Editor
1.1

 

Breathlessness: A multiprofessional approach to managing breathlessness
P Hunt, N Murtagh, H Barrett, D Laverty, D Lowrie, A Stevens Department of Palliative Care, The Royal Marsden Hospital, Fulham and Sutton
2.1
British Thoracic Oncology Group Third Annual National Meeting
Michael D Peake MB ChB FRCP Consultant Physician and Senior Lecturer in Respiratory Medicine, Thoracic Oncology Unit, Glenfield Hospital, Leicester
2.1
Bronchoscopy, Early diagnosis of lung cancer using
Joanna L Brown MD MRCP Respiratory Department, Portsmouth Hospitals NHS Trust; Jeremy M George MD FRCP Department of Thoracic Medicine, University College London Hospitals NHS Trust
1.4

 

Chemoradiotherapy: Chemoradiotherapy in the treatment of NSCLC
Richard Corkill MRCP FRCR, Pantelis Hadji Yiannakis MRCP FRCR Department of Oncology, Derriford Hospital, Plymouth
2.2
Chemotherapy in advanced NSCLC
Sally Moore MSC BSC(HONS) Macmillan Lung Cancer Nurse Specialist, Guy’s and St Thomas’ Hospital NHS Trust, London
1.1
Chemotherapy: Adjuvant chemotherapy for resected NSCLC: a new standard of care
Kenneth J O’Byrne MD MRCPI Consultant Oncologist, St James’s Hospital, Dublin
2.1
Chemotherapy: Firstline chemotherapy options for elderly patients
Riyaz Shah PhD MRCP Consultant Medical Oncologist, Kent Oncology Centre, Maidstone Hospital, Maidstone
3.2
Clinical review: A review of small cell lung cancer treatments
Tony Dhillon BSc MRCP Cancer Research UK Clinical Training Fellow, Imperial College; Honorary SpR in Medical Oncology, Imperial College Healthcare Trust; Michael J Seckl FRCP PhD Professor of Molecular Cancer Medicine, Imperial College; Honorary Consultant Medical Oncologist, Imperial College Healthcare Trust, London
5.3
  • View references
Clinical studies round-up
Richard Stephens, Research Scientist responsible for the Medical Research Council Clinical Trials Unit’s portfolio of lung cancer trials
1.3
Clinical studies round-up
Richard Stephens, Research Scientist responsible for the Medical Research Council Clinical Trials Unit’s portfolio of lung cancer trials.
1.4
Clinical studies round-up
Ian E Smith MD FRCP FRCPE Professor of Cancer Medicine at the Royal Marsden Hospital, Chairman of the NCRI Lung Cancer Clinical Studies Group
1.2
Clinical studies, A round-up of current
Ian E Smith MD FRCP FRCPE Professor of Cancer Medicine at the Royal Marsden Hospital, Chairman of the NCRI Lung Cancer Clinical Studies Group
1.1
Comment: ‘Taking stock’ of lung cancer treatment
Michael D Peake, Editor
5.1
Comment: A central role to play
Michael D Peake, Editor
3.4
Comment: Diagnosis, staging and making patients better informed
Michael D Peake, Editor
3.2
Comment: Pushing the boundaries of lung cancer care
Michael D Peake, Editor
3.3
Comment: Raising the public and political profile of lung cancer
Michael D Peake, Editor
4.1
Comment: The Cancer Reform Strategy – a window of opportunity
Michael D Peake, Editor
4.2
Comment: The case for specialist surgery
Michael D Peake, Editor
5.3
  • View references
Comment: The challenges of new therapies
Michael D Peake, Editor
5.2

 

Depression in lung cancer patients, How to assess and manage
Mari Lloyd-Williams MD FRCP MRCGP MMedSci ILTM Honorary Consultant in Palliative Medicine, University of Liverpool Medical School
1.3
Diagnosis: Lung cancer diagnosis: time for a new approach?
Trevor K Rogers MD FRCP Consultant Chest Physician, Chest Clinic, Doncaster Royal Infirmary
3.1
Diagnosis: The lung cancer nurse specialist at diagnosis
Helen R Jones RGN MSc(Res) Lead Clinician, Lung Cancer Multidisciplinary Team, Calderdale and Huddersfield NHS Foundation Trust, Huddersfield Royal Infirmary, Huddersfield
3.4
Diagnosis: Using ultrasound in the diagnosis and treatment of lung cancer
James Entwistle MBBS MRCP FRCR Consultant Radiologist; Achala Donuru MBBS MRCPCH DCH FRCR Specialist Registrar, Radiology Department, University Hospitals of Leicester
3.2
Diagnostics: Medical thoracoscopy and pleural effusions
Giles Cox FRCP MD Respiratory Consultant; Alys Burton MBBS Specialist Registrar; Nicola J Burrows MRCP Specialist Registrar; Nabeel J Ali FRCP DM Respiratory Consultant, Department of Respiratory Medicine, King’s Mill Hospital, Nottinghamshire
5.1
Diagnostics: Why patients delay
Ian Watson MB ChB MRCGP GP, Oldham
3.3
Drugs: Oral versus intravenous drugs for lung cancer
Jason F Lester MBBS MRCP FRCR Consultant Clinical Oncologist, Velindre Hospital, Cardiff
3.1

 

Earlier detection of lung cancer, The
Michael D Peake, Editor
1.4
Emergency hospital admissions: The impact of emergency hospital admissions for lung cancer in the UK
Colin Selby DM FRCPEDM FRCPE Consultant in Respiratory and Intensive Care Medicine, Queen Margaret Hospital, Fife
3.1
Endobronchial and endoscopic ultrasound
Robert Rintoul PhD FRCP Consultant Chest Physician, Papworth Hospital, Cambridge
5.2

 

Guidelines: The place of erlotinib in the NHS following NICE’s final guidance
Clive W Mulatero MA MB BChir MRCP PhD Senior Lecturer in Medical Oncology, St James’s Hospital, Leeds
5.3
  • View references

 

Investigation: Occupational risk factors for lung cancer
David Fishwick MBChB FRCP AFOM MD Reader in Respiratory Medicine and Honorary Consultant Respiratory Physician; Chris M Barber BMBS BMedSci MRCP AFOM MD Senior Lecturer in Respiratory Medicine and Honorary Consultant Respiratory Physician, University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust
3.3

 

Malignant mesothelioma presenting as a stroke in the absence of chest symptoms
Shaun Tolan MB BCh MRCP FRCR Clinical Research Fellow in Radiation Oncology, Princess Margaret Hospital, Toronto, Canada; Paul Burt MB BCh FRCP FRCR Consultant in Clinical Oncology, Christie Hospital, Manchester; Max Winson MB BCh BSc FRCP Consultant in General and Respiratory Medicine, Leighton Hospital, Cheshire
5.1
MDTs?, How effective are our
Michael D Peake, Editor
1.2
Mesothelioma, A new national resource centre for
Liz Darlison RN BSc(Hons) FETC Nurse Consultant, Glenfield Hospital, Leicester
1.2
Mesothelioma: Is routine prophylactic radiotherapy to chest drain sites useful in mesothelioma?
Noelle O’Rourke MA MD MRCP FRCR Consultant in Clinical Onocology; Rebecca Muirhead MB BCh MRCP SpR in Clinical Oncology, Beatson Oncology Centre, Gartnavel General Hospital, Glasgow
4.1
Mesothelioma: UK surgical trials in mesothelioma
Carol Tan MRCS Specialist Registrar; Tom Treasure MD MS FRCS Professor of Cardiothoracic Surgery, Thoracic Unit, Guy’s Hospital, London
3.2
Multidisciplinary working: The human face of lung cancer
Michael D Peake, Editor
2.2

 

NICE drug appraisals and new oncology treatments
Michael D Peake MB ChB FRCP Consultant Respiratory Physician, Glenfield Hospital, Leicester. National Clinical Lead for Lung Cancer
4.2
NICE guideline for lung cancer
Jesme Baird MB ChB MBA Director of Patient Care, The Roy Castle Lung Cancer Foundation
1.2
NICE: A NICE milestone
Michael D Peake, Editor
2.1
NICE: NICE guidelines will improve the diagnosis and treatment of lung cancer
2.1
Non-medical needs, Focus on patients’
Michael D Peake, Editor
1.3
NSCLC, The Scottish Medicines Consortium and lung cancer: one approach to treating
Alison Armour MB ChB BSc MSc MD MRCP FRCR Consultant Clinical Oncologist, Beatson Oncology Centre, Glasgow
1.2
NSCLC: Assessing performance status in patients with NSCLC
James S Myerson MRCP Respiratory Specialist Registrar and Clinical Research Fellow in Oncology; Craig Carden FRACP Clinical Research Fellow in Oncology; Mary ER O’Brien MD FRCP Consultant Medical Oncologist, The Lung Unit, The Royal Marsden Hospital, Sutton
3.4
NSCLC: Best supportive care in non-small cell lung cancer: has it changed?
Marianne C Nicolson MD BSc FRCP Consultant Medical Oncologist, Aberdeen Royal Infirmary, Aberdeen
3.2
NSCLC: Radiotherapy and brain metastases in NSCLC
Paula M Mulvenna BMedSci MBBS MRCP FRCR Consultant Clinical Oncologist, The Northern Centre for Cancer Treatment, Newcastle-upon-Tyne
3.4
NSCLC: Targeted therapies in non-small cell lung cancer
Rafaelle Califano MD Clinical Research Fellow in Medical Oncology; Fiona Blackhall MRCP PhD Consultant in Medical Oncology and Honorary Senior Lecturer, Department of Medical Oncology, Christie Hospital NHS Foundation Trust, Manchester
5.2
Nurses, Specialist lung cancer
Jesme Baird MB CHB MBA Director of Patient Care, The Roy Castle Lung Cancer Foundation
1.4

 

Palliative care: Making provisions for end-of-life care
Bernadette Devine BSc(Hons) MSc RGN Independent Consultant, Kent and Medway Cancer Network, B Devine Consultancy Ltd; Claire Henry RGN PGD BS(Hons) National Programme Director, NHS End of Life Care Programme; Anita Hayes SRN DN RNT Nurse Director, Kent and Medway Cancer Network
4.1
Palliative care: Quality of life in advanced NSCLC and effective disease control
Rosemary Lord MRCP Specialist Registrar; James Spicer MRCP PhD Consultant Medical Oncologist; Peter Harper FRCP Consultant Medical Oncologist, Dept Medical Oncology, Guy’s Hospital, London
3.3
Pancoast tumours: Current management of Pancoast tumours
Antonia Ugar MBBS F1 Doctor; Edward Black MBBS BSc FRCS(CTh) Consultant Thoracic Surgeon, Department of Thoracic Surgery, Nottingham City Hospital; Elaine Teh BMBS MRCS Cardiothoracic Specialist Registrar, The London Chest Hospital
5.1
Patient care: Ensuring appropriate and timely referral for the best patient care
David R Baldwin MD FRCP Consultant Physician, Respiratory Medicine Unit, David Evans Centre, Nottingham University Hospital, Nottingham
5.2
Patient care: Fatigue in lung cancer
Sharon de Caestecker RGN BN MA Head of Education, The Leicestershire and Rutland Hospice, Leicester
4.2
Patient care: Managing malignant pleural effusion
Peter Froeschle MD FETCS Consultant Thoracic Surgeon, Department of Thoracic and Upper GI Surgery, Royal Devon and Exeter Foundation Trust
3.4
Patient care: Nurse- and physiotherapy-led follow-up for lung cancer patients after surgery
Nicola Bell BSc(Hons) Dip Pall Care RGN DN Macmillan Lung Nurse Specialist; Vera Davison Diploma Physiotherapy (Belgium) SRP MCSP Physiotherapist Team Leader; Maggie Peat PhD BA RN Research Nurse, Harrogate and District NHS Foundation Trust Harrogate District Hospital
5.1
Patient care: The changing landscape of lung cancer management
Martin Walshaw MB ChB(Hons) MD FRCP Clinical Director, The Cardiothoracic Centre, Liverpool
3.3
Patient information: Accessing information
Jennifer Dickson BSc(Dist) Patient Network Manager; Jesme Baird MBChB MBA Medical Director, The Roy Castle Lung Cancer Foundation
2.2
Patient information: Creating a European cancer patient voice
Jesme Baird MB ChB MBA Director of Patient Care, The Roy Castle Lung Cancer Foundation. Steering Group Member, The European Cancer Patient Coalition
2.1
Patient information: The benefits of copying your correspondence to patients
Simon Taggart BSc MD FRCP Lead Lung Cancer Clinician for Salford and Trafford NHS Trusts
3.2
Patient management: Neuro-endocrine tumours of the lung
John R Gosney BSc MD FRCPath Consultant Thoracic Pathologist, Royal Liverpool University Hospital; Reader in Thoracic Pathology, University of Liverpool
4.2
PET scanning in non-small cell lung cancer, The role of
Thomas Nunan MD FRCP Nuclear Medicine Consultant, Clinical PET Centre, Guy’s and St Thomas’ Hospital NHS Trust, London
1.1
PET: PET/CT imaging in lung malignancies
Michael J O’Doherty MSc MD FRCP Consultant in Nuclear Medicine, The PET Imaging Centre, St Thomas’ Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London
4.2
Pin-prick analgesia: Cordotomy for the relief of malignant chest wall pain
Derek Pounder MB ChB DA FRCA Consultant Anaesthetist and Specialist in Pain Medicine, Department of Pain Medicine, St Mary’s Hospital, Portsmouth
3.3
Policy making, The Lung Cancer Advisory Group: contributing to
Mike Richards CBE National Cancer Director for England, Chair of the Lung Cancer Advisory Group
1.3
Poor performance status patients and the TOPICAL trial
Grant Stewart MBBS MRCP; Siow Ming Lee PhD FRCP Whittington and University College London Hospitals
1.3
Practice-based commissioning: How practice-based commissioning will affect patients
Orest Mulka BA MBBS FRCGP GP, Measham and Macmillan GP Facilitator, Cancer Lead, Charnwood and North West Leicestershire Primary Care Trust
3.1
Primary care: The management of lung cancer in primary care
Michael D Peake, Editor
3.1

 

Quality of life assessment in lung cancer patients, Overview of
Pauline Leonard RGN MBBS(Hons) MRCP Consultant Medical Oncologist, Southend Hospital Cancer Centre
1.4

 

Radiotherapy: Advanced radiotherapy treatment options
Pooja Jain MRCP FRCR Consultant Clinical Oncology, Clatterbridge Centre for Oncology, Wirral; Carl Graham Rowbottom PhD Northwestern Medical Physics; Corrine Faivre-Finn FRCR MD PhD Honorary Senior Lecturer and Consultant Clinical Oncology, Christie Hospital, Manchester
5.2

 

Satellite symposium: Understanding patient needs: a tailored approach
David R Ferry PhD FRCP Professor of Medical Oncology, New Cross Hospital, Wolverhampton
2.1
Secondline chemotherapy in NSCLC
Leila Khoja MbChB MRCP Specialist Registrar; Mohammed Mulyati MBBS MRCP Clinical Fellow Siow Ming Lee PhD FRCP Consultant Medical Oncologist, Whittington and University College Hospitals, London
3.1
Secondline chemotherapy, The value of
Jean Baker RN RSCN Dip Prof Prac Cert Ed Macmillan Lung Cancer Nurse Specialist, Cardiff and the Vale NHS Trust
1.2
Service development: Improving mesothelioma services
Liz Darlison BSc(Hons) RN FETC Consultant Nurse, Thoracic Oncology – Mesothelioma, Glenfield Hospital, Leicester
5.3
  • View references
Service provision: Capacity planning for lung cancer services
Michael D Peake MB ChB FRCP Consultant Respiratory Physician, Glenfield Hospital, Leicester. National Clinical Lead for Lung Cancer
4.1
Smoking: Smoking cessation and lung cancer
Elin Roddy MRCP Specialist Registrar; Mike Ward DM FRCP Consultant Physician, Department of Respiratory Medicine, King’s Mill Hospital, Nottinghamshire
4.1
Surgery for non-small cell lung cancer, Patient experience of
Nicola Bell BSc(Hons) Lung Cancer Nurse Specialist, Harrogate Health Care NHS Trust, North Yorkshire
1.4

 

Therapeutics: Patient selection for chemotherapy
Dean A Fennell PhD FRCP Cancer Research UK Clinician Scientist; Consultant and Senior Lecturer in Thoracic Medical Oncology, Queen’s University, Belfast; Paula Scullin PhD MRCP Locum Consultant in Medical Oncology, Northern Ireland Cancer Centre, Belfast City Hospital
5.3
  • View references
TKIs: Epidermal growth factor TKIs
David J Dunlop BSc(Hons) MB ChB MSc FRCP (Lond, Glas) FRSM Consultant Medical Oncologist, Beatson Oncology Centre, Western Infirmary, Glasgow
2.2
Treatment options: Multimodality therapy
Lorraine M Creech MA RGN Diploma HE Professional Health Studies NDNcert ENB931 Macmillan Lung Cancer Nurse, East Cheshire NHS Trust, Macclesfield
2.2
Treatment options: The management of common toxicities related to erlotininb
John McPhelim RGN DipCN BSc(Hons) Lead Lung Cancer Nurse, NHS Lanarkshire; Lead Lung Cancer Nurse, West of Scotland, Lung Cancer Managed Clinical Network
3.4
Treatment: High-risk bronchial carcinoma resections
Antonio E Martin-Ucar FRCS (CTh) Consultant Thoracic Surgeon, Department of Thoracic Surgery, Glenfield Hospital, Leicester
5.3
  • View references
Treatment: Switching from IV to oral lung cancer treatments
Steve Williamson PGDip Onc MRPharmS Consultant Pharmacist in Cancer Services, Northumbria Healthcare NHS Foundation Trust; Melanie Hall RN BSc(Hons) MSc Oncology Nurse Consultant Oncology, Lead Nurse Cancer Services, City Hospitals Sunderland NHS Foundation Trust
5.1
Trials update: Identifying patients who may MERIT from Tarceva®
Stephen Falk FRCR FRCP MD Consultant Clinical Oncologist, Bristol Haematology and Oncology Centre, Bristol
4.1

 


The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.
Copyright (©) 2010 Hayward Group Ltd. The title Lung Cancer in Practice is the property of Hayward Group Ltd and, together with the content, is bound by copyright. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk